Market Dynamics
Global cardiopulmonary resuscitation market drivers
Rising prevalence of heart and respiratory diseases
Heart disease is the primary cause of death for both men and women worldwide. According to the American College of Cardiology, an American will experience a myocardial infarction every 40 seconds. It went on to say that in 2017, emergency medical services assessed 356,461 Americans to have experienced out-of-hospital cardiac arrest; emergency medical services treatment was started in 52% of those cases. Only 18.7% of the patients had an initial heart rhythm shockable by an automated external defibrillator, ventricular fibrillation, or ventricular tachycardia.
10.4% of adults survived hospital discharge, and 8.4% had good functional status. Additionally, according to NHS England, respiratory disease is the 3rd leading cause of death in England, affecting one in five people (after cancer and cardiovascular disease). Patients with cardiac and respiratory problems have a higher chance of survival when CPR is performed effectively. Applying CPR as soon as possible can dramatically increase sufferers’ survival chances. According to an American Heart Association survey, 70% of Americans feel helpless in a cardiac emergency because they cannot perform CPR.
Global cardiopulmonary resuscitation market restraint:
Simplicity of manual cpr techniques
Early cardiopulmonary resuscitation is one of a series of coordinated steps required for adequate resuscitation (CPR). Heart and brain resuscitation may both benefit from high-quality CPR. An automatic load-distributing band (LDB) chest compression equipment produces more blood flow to essential organs than a manual chest compression device, which may lead to better resuscitation outcomes. The tiredness rescuers endure when performing manual CPR is one of the most frequent issues. On the other hand, automatic devices don't get tired and can keep massaging even while complementing procedures like defibrillation. These elements are anticipated to restrict the market's expansion for cardiopulmonary resuscitation worldwide.
Global cardiopulmonary resuscitation market opportunities:
Automated cpr medical device
Recent research and numerous cases have demonstrated that manual chest compression during CPR is less effective than in a natural clinical environment. Clinical studies have shown that mechanical and automated compression devices can improve hemodynamic effect and coronary perfusion and increase the incidence of restoration of spontaneous circulation. Medical specialists' evaluation of CPR techniques indicated that chest compressions are infrequent and inefficient. They have considerable pauses during contraction, which lowers the survival rate. These shortcomings have been overcome by mechanically automated chest compression devices used in mechanical CPR. In doing so, the limitations of traditional manual CPR may be overpowered, perhaps improving perfusion pressures. Applying CPR as soon as possible can dramatically increase sufferers’ survival chances.
Regional Analysis
The global cardiopulmonary resuscitation market is divided into four regions: North America, Europe, Asia-Pacific, and LAMEA.
North america dominates the global market
North America is the major revenue contributor and is expected to grow at a CAGR of 11.25% during the forecast period. During the projection period, North America is anticipated to grow at a profitable growth rate. The dominance of North America is attributed to the increase in heart disease and lifestyle-related illnesses. In 2017, the most significant portion of global revenue was produced in North America. Since the last ten years, the number of out-of-hospital cardiac arrests has grown in the U.S. The change toward a sedentary lifestyle increased obesity prevalence, and other chronic heart diseases are anticipated to increase the frequency of heart disease deaths in this region.
Europe is expected to grow at a CAGR of 11.05% during the forecast period. The second-largest market for cardiopulmonary resuscitation is in Europe. The market in this region is expanding due to factors like well-established paramedical and emergency medical services, an increased frequency of heart disorders in the senior population, improving economies, high disposable income per person, and rising healthcare spending. The biggest markets in Europe for cardiopulmonary resuscitation are the U.K. and Germany. Another important reason driving this region's lucrative growth is an increase in the frequency of cardiac arrests.
The Asia-Pacific area held the third-largest market share due to unrealized potential, governmental initiatives, and increased cardiac arrests. A rising senior population, more chronic diseases, and more use of medical devices in healthcare are driving this region's growth. The other significant factors driving the market expansion in the Asia Pacific region are the enhancement of emergency paramedical services, increasing acceptance of monitoring devices, and growing public awareness of medical equipment.
LAMEA holds an important place in the market. With less economic development and meager income, the Middle East and Africa had the smallest market share in 2019; this will likely change as more people develop heart and respiratory ailments and healthcare infrastructure develops quickly. For instance, the Dubai Health Authority reports that 32% of UAE residents have high blood pressure, with excessive stress being a major contributing factor, and that roughly 30% of the population suffers from heart disease, which has become a leading cause of death in the country. Expanding medical tourism and high disposable income levels will also propel market expansion in this area.
Segmental Analysis
The global cardiopulmonary resuscitation market is segmented by product type, compressor type, application, and end-user.
Based on product type, the global cardiopulmonary resuscitation market has been segmented into piston CPR devices, a load-distributing band (LDB), active compression-decompression (ACD) devices, and impedance devices threshold devices, extracorporeal techniques, invasive perfusion devices, and others.
The piston CPR devices segment is the major contributor to the market and is estimated to grow at a CAGR of 11.70% during the forecast period. The first mechanical CPR devices used piston-based mechanisms were introduced in the 1960s. The following few decades saw the creation of innovations like load distribution bands and vest-CPR. A piston device with an active chest recoil mechanism is the LUCAS 2 Chest Compression System, made by Jolie AB in Sweden and marketed by Physio-Control Inc., a division of Stryker Corporation. The ability of these devices to reliably produce high-quality chest compressions, which have been linked to enhanced intra-arrest hemodynamic profiles, is their main theoretical advantage. Piston devices drive a piston positioned over the patient's lower sternum using compressed gas. Some of these piston devices offer CPR using a suction cup attachment.
The International Liaison Committee on Resuscitation emphasizes the importance of high-quality chest compressions (i.e., correct depth, pace, full release, and high chest compression fraction) (ILCOR). The AutoPulse Resuscitation System is a ZOLL Medical Corporation product with a CE certification. A platform, a wide band that wraps around the patient's chest, and a power system comprise the load-distributing band (LDB) system. On the thoracic pump principle, an LDB is based. Along with compressing the chest, it also raises the intrathoracic pressure, which causes blood flow.
Based on compressor type, the global cardiopulmonary resuscitation market has been bifurcated into manual CPR and automatic mechanical CPR.
The automatic mechanical CPR segment is the major contributor to the market and is estimated to grow at a CAGR of 10.90% during the forecast period. Automated cardiopulmonary resuscitation (CPR) is receiving fresh attention in the United States because it offers reliable CPR depths and rates, which have been thought essential for maximizing survival. The availability of different battery- and pneumatic-powered automatic mechanical CPR devices, including The Ortus Group's Corpus CPR and Koninklijke Philips N.V.'s improved Q-CPR measuring and feedback tool, is anticipated to increase the automatic mechanical CPR segment's market share. The popularity of automated mechanical CPR is growing due to its simplicity in reducing rescuer fatigue and the incorporation of measurement equipment.
Learning and practicing high-quality manual CPR for a very long time can be challenging. The chest does not always recoil during manual CPR due to increased chest wall compliance, a common issue (softens). In a recently concluded clinical research, patients getting manual active compression/decompression CPR with a suction cup paired with an impedance threshold device (ITD) had better survival and a positive neurologic outcome than those receiving manual CPR. Ivor Medical (Croatia) makes clever emergency response system solutions. The business is developing several cardiopulmonary resuscitation products (CPR) and has created the CPR Pro Cradle device and CPR Pro software for emergency response.
Based on application, the global cardiopulmonary resuscitation market has been classified as ambulances, emergency departments, coronary and intensive care units, cardiac catheterization labs, organ transplant facilities, air medevac units, and EMT rescue units.
The EMT rescue unit segment is the major contributor to the market and is estimated to grow at a CAGR of 12.70% during the forecast period. EMTs and paramedics attend crises involving multiple vehicles on the highway and people experiencing heart attacks at home. To prevent vehicle accidents with significant injuries, wilderness rescues, airplane crashes, and other natural disasters resulting in traumatic injuries, emergency medical services (EMS) units work for private, hospital-based, municipal, and fire departments.
Due to the vast number of people with lung cancer, cardiovascular illnesses, and pulmonary disorders, the coronary and intensive care unit market is expected to expand throughout the forecast period. In addition to the condition described, pandemic scenarios are anticipated to increase the number of patients needing critical care and coronary care units. Among cancer patients who were brought to an intensive care unit after experiencing cardiac arrest, a 2015 multicenter study conducted in France revealed a 14% 6-month survival rate (ICU). Only 5.8% of cancer patients got CPR during their hospital stay in a comprehensive cancer center's closed medical-surgical intensive care unit (ICU) in Amman, Jordan, according to another study of 104 patients who experienced a cardiac arrest.
The most often transplanted organs globally are the kidneys, the liver, and, lastly, the heart. The most frequently transplanted tissues are musculoskeletal and corneal grafts, which outweigh organ transplants by a factor of more than ten. Living, brain-dead, or circulatory-death deceased individuals can all donate organs. As of March 2020, roughly 112,000 men, women, and children were on the national transplant waiting list. In contrast to the Asia-Pacific area, where 37,816 transplants were carried out in 2018, the US performed 39,718 transplants in 2019.
Based on the end-user, the global cardiopulmonary resuscitation market has been divided into hospitals and clinics, cardiac catheterization laboratories, organ transplant units, and others.
The hospital and clinic segment is the major contributor to the market and is estimated to grow at a CAGR of 12.50% during the forecast period. The end-user segment's fastest-growing category is anticipated to be the hospitals and clinics segment. The rising awareness of the diagnosis of numerous cardiovascular diseases and arrhythmias is to blame. The prevalence of atrial fibrillation in the U.S. ranged from 2.7 to 6.1 million, according to the Centers for Disease Control and Prevention (CDC). It is anticipated that this number will rise as the population ages. As these facilities serve as the primary sites for patients obtaining cardiac arrest diagnosis and treatment, hospitals held the highest market share in 2019.
One of the most often carried-out heart operations is cardiac catheterization. Annually, more than 1,000,000 cardiac catheterization procedures are carried out in the United States. Complications relating to the patient and the technique are typical in any invasive procedure. The incidence of these problems has dramatically decreased thanks to improvements in cardiac catheterization equipment, operator expertise, and innovative designs.
Academic and research institutions that provide CPR instruction to staff, students, and others make up the other segment. According to a statistic from the U.S. Occupational Safety and Health Administration, there are around 10,000 cardiac arrests at work each year in the country. 55 percent of the 2,000 workers in corporate offices who work in the hospitality, education, and industry/labor sectors need to receive first aid, CPR, or AED training from their company. Home is the location of 68.5% of cardiac arrests outside of hospitals. The Australian and New Zealand Committee on Resuscitation (ANZCOR) recommends that CPR skills be updated at least once a year; however, because this may not be practical for all industries, ANZCOR believes that first-aider refresher training every two years is an excellent opportunity for people to use their skills and stay current with the latest procedures.
